2026 NPPES data Pharmacist NPI 1447692652 PHARM.D
Verify on CMS →

MATTHEW KAMADA, PHARM.D

Pharmacist in BELLFLOWER, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 372 beneficiaries · Pharmacist avg: 135
Generic prescribing
75%
generic claims · 25% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MATTHEW KAMADA, PHARM.D filed 1,107 Medicare Part D claims in 2023 as a Pharmacist in BELLFLOWER, California, prescribing 75% generic.

1K
Part D claims, 2023
75%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MATTHEW KAMADA, PHARM.D's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,107 Top 23% higher than 77% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). This entry sits in this band. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about MATTHEW KAMADA, PHARM.D?

Quality data not reported

NPI registry status

Active

Issued 07/29/2013

NPI 1447692652

Primary specialty

Pharmacist

High-volume

290,447 US NPIs in this specialty

Medicare Part D claims

1,107 720% vs specialty avg

2023 prescription claims

Specialty avg: 135

Specialty distribution in California

How Pharmacist compares to other specialties among California providers

California providers

Pharmacist share within California

1. Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MATTHEW KAMADA, PHARM.D appears in the CMS NPPES registry as a Pharmacist provider holding PHARM.D credentials at 9400 ROSECRANS AVE, BELLFLOWER, CA, 90706, with a listed phone of (562) 461-6064. NPI 1447692652 was issued on 07/29/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KAMADA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,107 prescription claims written by this provider, covering 372 Medicare beneficiaries and totaling roughly $110K in drug spend, split 25% brand-name and 75% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

9400 ROSECRANS AVE
BELLFLOWER, CA 90706

Provider Details

NPI 1447692652
Specialty Pharmacist
Credentials PHARM.D
Gender Male
NPI Issued 07/29/2013

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MATTHEW KAMADA, PHARM.D. To verify MATTHEW KAMADA, PHARM.D's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MATTHEW KAMADA, PHARM.D — brand share 25.0%
Specialty average (est.)

25% brand-name claims vs 75% generic, on 1,107 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,107
Total Claims
$110K
Total Drug Cost
372
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,271
Total Day Supply
98,153
Brand vs Generic
25% brand / 75% generic
Brand Drug Cost
$97K
Generic Drug Cost
$12K

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
0.97
Gender Split
61% female / 39% male
Age Distribution
<65: 12, 65-74: 231, 75-84: 112, 85+: 17

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MATTHEW KAMADA, PHARM.D prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Amlodipine Besylate
167
Losartan Potassium
102
Glipizide
87
Jardiance
Empagliflozin
64
Humulin N
Insulin Nph Human Isophane
53
Lisinopril
51
Metformin Hcl Er
Metformin Hcl
50
Rosuvastatin Calcium
40
Humulin N Kwikpen
Insulin Nph Human Isophane
38
Metformin Hcl
32

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Overview

How MATTHEW KAMADA, PHARM.D fits within the Pharmacist landscape nationally.

290,447
Pharmacist Providers in US
56
States with Pharmacist
135
Avg Claims per Provider

MATTHEW KAMADA, PHARM.D's 1,107 claims are above the specialty average of 135.

Nearby Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as KAMADA.

Compare Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MATTHEW KAMADA, PHARM.D's specialty?
MATTHEW KAMADA, PHARM.D specializes in Pharmacist and practices in BELLFLOWER, California. Credentials: PHARM.D.
How much does MATTHEW KAMADA, PHARM.D prescribe under Medicare Part D?
In 2023, MATTHEW KAMADA, PHARM.D wrote 1,107 Medicare Part D claims totaling $110K in drug costs for 372 beneficiaries.
Where is MATTHEW KAMADA, PHARM.D located?
MATTHEW KAMADA, PHARM.D is located at 9400 ROSECRANS AVE, BELLFLOWER, CA, 90706. Phone: (562) 461-6064.
What is MATTHEW KAMADA, PHARM.D's NPI number?
MATTHEW KAMADA, PHARM.D's National Provider Identifier (NPI) is 1447692652, issued on 07/29/2013.
Does MATTHEW KAMADA, PHARM.D prescribe more brand-name or generic drugs?
MATTHEW KAMADA, PHARM.D's prescribing is 25% brand-name and 75% generic drugs by claim count, with $97K in brand drug costs.
How many Pharmacist providers are there in the US?
There are 290,447 Pharmacist providers across 56 states in the US. The average Pharmacist provider writes 135 Medicare Part D claims per year.
What drugs does MATTHEW KAMADA, PHARM.D prescribe most often?
Based on 2023 Medicare Part D data, MATTHEW KAMADA, PHARM.D's most frequently prescribed drugs include Amlodipine Besylate, Losartan Potassium, Glipizide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MATTHEW KAMADA, PHARM.D accept Medicare?
MATTHEW KAMADA, PHARM.D appears in CMS Medicare data with 1,107 Part D claims and 372 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MATTHEW KAMADA, PHARM.D's credentials?
MATTHEW KAMADA, PHARM.D's NPI is 1447692652 with credentials PHARM.D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology